Literature DB >> 33730090

Prognostic role of perioperative acid-base disturbances on the risk of Clostridioides difficile infection in patients undergoing cardiac surgery.

Anna Rzucidło-Hymczak1, Hubert Hymczak2, Anna Kędziora3, Bogusław Kapelak3, Rafał Drwiła4, Dariusz Plicner5.   

Abstract

BACKGROUND: It is unclear whether acid-base balance disturbances during the perioperative period may impact Clostridium difficile infection (CDI), which is the third most common major infection following cardiac surgery. We hypothesized that perioperative acid-base abnormalities including lactate disturbances may predict the probability of incidence of CDI in patients after cardiac procedures.
METHODS: Of the 12,235 analyzed patients following cardiac surgery, 143 (1.2%) developed CDI. The control group included 200 consecutive patients without diarrhea, who underwent cardiac procedure within the same period of observation. Pre-, intra and post-operative levels of blood gases, as well as lactate and glucose concentrations were determined. Postoperatively, arterial blood was drawn four times: immediately after surgery and successively; 4, 8 and 12 h following the procedure.
RESULTS: Baseline pH was lower and PaO2 was higher in CDI patients (p < 0.001 and p = 0.001, respectively). Additionally, these patients had greater base deficiency at each of the analyzed time points (p < 0.001, p = 0.004, p = 0.012, p = 0.001, p = 0.016 and p = 0.001, respectively). Severe hyperlactatemia was also more common in CDI patients; during the cardiac procedure, 4 h and 12 h after surgery (p = 0.027, p = 0.004 and p = 0.001, respectively). Multivariate logistic regression analysis revealed that independent risk factors for CDI following cardiac surgery were as follows: intraoperative severe hyperlactatemia (OR 2.387, 95% CI 1.155-4.933, p = 0.019), decreased lactate clearance between values immediately and 12 h after procedure (OR 0.996, 95% CI 0.994-0.999, p = 0.013), increased age (OR 1.045, 95% CI 1.020-1.070, p < 0.001), emergent surgery (OR 2.755, 95% CI 1.565-4.848, p < 0.001) and use of antibiotics other than periprocedural prophylaxis (OR 2.778, 95% CI 1.690-4.565, p < 0.001).
CONCLUSION: This study is the first to show that perioperative hyperlactatemia and decreased lactate clearance may be predictors for occurrence of CDI after cardiac surgery.

Entities:  

Year:  2021        PMID: 33730090      PMCID: PMC7968627          DOI: 10.1371/journal.pone.0248512

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  30 in total

1.  [Hyperlactatemia and lactic acidosis in the critically ill patient].

Authors:  Nawfel Ben-Hamouda; Laurence Haesler; Lucas Liaudet
Journal:  Rev Med Suisse       Date:  2013-12-11

2.  The effect of Clostridium difficile infection on cardiac surgery outcomes.

Authors:  Anthony Lemaire; Viktor Dombrovskiy; George Batsides; Peter Scholz; Al Solina; Nicholas Brownstone; Alan Spotnitz; Leonard Y Lee
Journal:  Surg Infect (Larchmt)       Date:  2014-11-17       Impact factor: 2.150

Review 3.  Clostridium difficile colitis: A clinical review.

Authors:  Gabie K B Ong; Tobi J Reidy; Matthew D Huk; Frederick R Lane
Journal:  Am J Surg       Date:  2017-01-03       Impact factor: 2.565

Review 4.  Hyperlactatemia and Cardiac Surgery.

Authors:  Jonathon Minton; David A Sidebotham
Journal:  J Extra Corpor Technol       Date:  2017-03

5.  Clostridioides difficile infection after cardiac surgery: Assessment of prevalence, risk factors and clinical outcomes-retrospective study.

Authors:  Anna Rzucidło-Hymczak; Hubert Hymczak; Aldona Olechowska-Jarząb; Anna Gorczyca; Boguslaw Kapelak; Rafał Drwiła; Dariusz Plicner
Journal:  PeerJ       Date:  2020-09-29       Impact factor: 2.984

6.  Increased number of Clostridium difficile infections and prevalence of Clostridium difficile PCR ribotype 001 in southern Germany.

Authors:  S Borgmann; M Kist; T Jakobiak; M Reil; E Scholz; C von Eichel-Streiber; H Gruber; J S Brazier; B Schulte
Journal:  Euro Surveill       Date:  2008-12-04

7.  A multi-institutional cohort study confirming the risks of Clostridium difficile infection associated with prolonged antibiotic prophylaxis.

Authors:  Katherine A Kirkwood; Brian C Gulack; Alexander Iribarne; Michael E Bowdish; Giampaolo Greco; Mary Lou Mayer; Karen O'Sullivan; Annetine C Gelijns; Nishit Fumakia; Ravi K Ghanta; Jesse M Raiten; Anuradha Lala; Joseph S Ladowski; Eugene H Blackstone; Michael K Parides; Alan J Moskowitz; Keith A Horvath
Journal:  J Thorac Cardiovasc Surg       Date:  2017-09-28       Impact factor: 5.209

Review 8.  Clostridium difficile infection: review.

Authors:  Jacek Czepiel; Mirosław Dróżdż; Hanna Pituch; Ed J Kuijper; William Perucki; Aleksandra Mielimonka; Sarah Goldman; Dorota Wultańska; Aleksander Garlicki; Grażyna Biesiada
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-04-03       Impact factor: 3.267

9.  Serum lactate and phosphate as biomarkers of intestinal ischemia in a Ugandan tertiary hospital: a cross-sectional study.

Authors:  Ronald Kintu-Luwaga; Moses Galukande; Francis N Owori
Journal:  Int J Emerg Med       Date:  2013-12-04

10.  Healthcare associated Clostridioides difficile infection in adult surgical and medical patients hospitalized in tertiary hospital in Belgrade, Serbia: a seven years prospective cohort study.

Authors:  Vesna Šuljagić; Bojana Milenković; Aneta Perić; Dragutin Jovanović; Vesna Begović-Kuprešanin; Srđan Starčević; Aleksandar Tomić; Sandra Vezmar Kovačević; Viktorija Dragojević-Simić
Journal:  Libyan J Med       Date:  2020-12       Impact factor: 1.657

View more
  1 in total

Review 1.  Interactions between NLRP3 inflammasome and glycolysis in macrophages: New insights into chronic inflammation pathogenesis.

Authors:  Qun Yu; Maojuan Guo; Wenyun Zeng; Miao Zeng; Xiaolu Zhang; Yue Zhang; Wenlan Zhang; Xijuan Jiang; Bin Yu
Journal:  Immun Inflamm Dis       Date:  2021-12-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.